Advisor Partners LLC Regeneron Pharmaceuticals, Inc. Transaction History

Advisor Partners LLC

  • $1.42 Billion
  • Q2 2022

A detailed history of Advisor Partners LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Partners LLC holds 1,677 shares of REGN stock, worth $1.19 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,677
Previous 1,754 4.39%
Holding current value
$1.19 Million
Previous $1.23 Million 19.1%
% of portfolio
0.07%
Previous 0.08%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$548.35 - $738.84 $42,222 - $56,890
-77 Reduced 4.39%
1,677 $991,000
Q1 2022

Apr 27, 2022
BUY
$595.12 - $698.43 $104,741 - $122,923
176 Added 11.15%
1,754 $1.23 Million
Q4 2021

Feb 04, 2022
BUY
$543.48 - $670.97 $14,130 - $17,445
26 Added 1.68%
1,578 $997,000
Q3 2021

Nov 15, 2021
BUY
$574.03 - $680.96 $17,794 - $21,109
31 Added 2.04%
1,552 $939,000
Q2 2021

Aug 12, 2021
SELL
$472.8 - $558.54 $27,895 - $32,953
-59 Reduced 3.73%
1,521 $850,000
Q1 2021

Jun 01, 2021
SELL
$446.73 - $548.2 $56,287 - $69,073
-126 Reduced 7.39%
1,580 $748,000
Q4 2020

Feb 17, 2021
SELL
$478.3 - $607.98 $224,801 - $285,750
-470 Reduced 21.6%
1,706 $824,000
Q3 2020

Nov 19, 2020
SELL
$544.75 - $658.21 $138,366 - $167,185
-254 Reduced 10.45%
2,176 $1.22 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $311,284 - $406,313
631 Added 35.08%
2,430 $1.52 Million
Q1 2020

May 15, 2020
BUY
$336.18 - $494.43 $313,655 - $461,303
933 Added 107.74%
1,799 $878,000
Q4 2019

Jan 24, 2020
BUY
$274.13 - $376.51 $11,513 - $15,813
42 Added 5.1%
866 $338,000
Q3 2019

Oct 16, 2019
BUY
$273.46 - $318.39 $17,774 - $20,695
65 Added 8.56%
824 $229,000
Q2 2019

Jul 26, 2019
SELL
$299.6 - $414.82 $128,828 - $178,372
-430 Reduced 36.16%
759 $238,000
Q1 2019

Apr 23, 2019
SELL
$372.08 - $439.57 $8,557 - $10,110
-23 Reduced 1.9%
1,189 $488,000
Q4 2018

Jan 29, 2019
BUY
$335.82 - $403.04 $85,634 - $102,775
255 Added 26.65%
1,212 $453,000
Q3 2018

Nov 06, 2018
BUY
$351.14 - $408.51 $21,068 - $24,510
60 Added 6.69%
957 $387,000
Q2 2018

Jul 25, 2018
BUY
$284.6 - $344.99 $7,968 - $9,659
28 Added 3.22%
897 $309,000
Q1 2018

May 03, 2018
SELL
$315.82 - $393.78 $227,074 - $283,127
-719 Reduced 45.28%
869 $299,000
Q4 2017

Jan 26, 2018
BUY
$358.63 - $469.95 $4,303 - $5,639
12 Added 0.76%
1,588 $590,000
Q3 2017

Nov 03, 2017
BUY
$431.38 - $504.0 $679,854 - $794,304
1,576
1,576 $705,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Advisor Partners LLC Portfolio

Follow Advisor Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email